[1] 李红,单海燕.老年非瓣膜性心房颤动患者的抗凝治疗现状[J]. 中华全科医师杂志,2021,20(1):107-110. [2] KIM D,YANG P S,YU H T, et al. Risk of dementia in stroke-free patients diagnosed with atrial fibrillation: data from a population-based cohort[J]. Eur Heart J,2019,40(28):2313-2323. [3] KIRCHHOF P,BENUSSI S,KOTECHA D,et al.2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS[J]. Eur Heart J,2016,37(38):2893-2962. [4] CHAO T F, LIU C J, WANG K L, et al.Using the CHA2DS2-VASc score for refining stroke risk stratification in‘low-risk' Asian patients with atrial fibrillation[J]. J Am Coll Cardiol,2014,64(16) : 1658-1665. [5] CHAO T F,LIU C J,TUAN T C,et al.Comparisons of CHADS2 and CHA2DS2-VASc scores for stroke risk stratification in atrial fibrillation: which scoring system should be used for Asians? [J]. Heart Rhythm, 2016,13(1) : 46-53. [6] JOUNDI R A, CIPRIANO L E, SPOSATO L A, et al. Ischemic stroke risk in patients with atrial fibrillation and CHA2DS2-VASc of 1: systematic review and meta analysis[J]. Stroke, 2016, 47(5) : 1364-1367. [7] 方传勤,吴小三,李影,等. 颈动脉斑块对非瓣膜病心房颤动患者卒中短期不良结局的影响[J]. 中华老年医学杂志,2016,35(3):247-251. [8] 中华医学会神经病学分会, 中华医学会神经病学分会脑血管病学组.中国急性缺血性脑卒中诊治指南2018[J]. 中华神经科杂志,2018,51(9):666-682. [9] 何浩辉,郭军. 评估肺动脉收缩压在非瓣膜性心房颤动患者中缺血性脑卒中事件的预测价值[J]. 暨南大学学报(自然科学与医学版),2021,42(3):309-313. [10] 朱明娜,张丽华.心房颤动伴高血压患者动态动脉硬化指数与缺血性脑卒中的相关性[J].中国循证心血管医学杂志,2021,13(12):1460-1463,1467. [11] CHO D H, CHOI J I, CHOI J, et al.Impact of carotid atherosclerosis in CHA2DS2-VASc-based risk score on predicting ischemic stroke in patients with atrial fibrillation[J]. Korean J Intern Med,2021,36(2):342-351. [12] 黄锐,雷玉华,赵劲波,等. 首诊非瓣膜性心房颤动患者E/e′及颈动脉粥样硬化斑块与缺血性脑卒中的关系[J].华中科技大学学报(医学版),2021,50(5):632-639. [13] 孙静娴,李静,蔡静波,等. 左心房内径与非瓣膜性房颤患者缺血性脑卒中风险的相关性分析[J].实用临床医药杂志,2021,25(11):35-38. [14] 李欣,刘璐,柳志红,等. 口服抗凝剂在非瓣膜性房颤伴慢性肾功能不全患者中的应用进展[J].协和医学杂志,2022,13(2):302-307. |